These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17340635)

  • 1. Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures.
    Arai R; Ito K; Ohnishi T; Ohba H; Akasaka R; Bessho Y; Hanawa-Suetsugu K; Yoshikawa T; Shirouzu M; Yokoyama S
    Proteins; 2007 May; 67(3):732-42. PubMed ID: 17340635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
    Sjøholt G; Ebstein RP; Lie RT; Berle JØ; Mallet J; Deleuze JF; Levinson DF; Laurent C; Mujahed M; Bannoura I; Murad I; Molven A; Steen VM
    Mol Psychiatry; 2004 Jun; 9(6):621-9. PubMed ID: 14699425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.
    Ohnishi T; Ohba H; Seo KC; Im J; Sato Y; Iwayama Y; Furuichi T; Chung SK; Yoshikawa T
    J Biol Chem; 2007 Jan; 282(1):637-46. PubMed ID: 17068342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients.
    Sjøholt G; Gulbrandsen AK; Løvlie R; Berle JO; Molven A; Steen VM
    Mol Psychiatry; 2000 Mar; 5(2):172-80. PubMed ID: 10822345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.
    Ohnishi T; Yamada K; Ohba H; Iwayama Y; Toyota T; Hattori E; Inada T; Kunugi H; Tatsumi M; Ozaki N; Iwata N; Sakamoto K; Iijima Y; Iwata Y; Tsuchiya KJ; Sugihara G; Nanko S; Osumi N; Detera-Wadleigh SD; Kato T; Yoshikawa T
    Neuropsychopharmacology; 2007 Aug; 32(8):1727-37. PubMed ID: 17251911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis between polymorphisms in the myo-inositol monophosphatase 2 (IMPA2) gene and bipolar disorder.
    Bloch PJ; Weller AE; Doyle GA; Ferraro TN; Berrettini WH; Hodge R; Lohoff FW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1515-9. PubMed ID: 20800640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.
    Nakayama J; Yamamoto N; Hamano K; Iwasaki N; Ohta M; Nakahara S; Matsui A; Noguchi E; Arinami T
    Neurology; 2004 Nov; 63(10):1803-7. PubMed ID: 15557493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral analyses of transgenic mice harboring bipolar disorder candidate genes, IMPA1 and IMPA2.
    Ohnishi T; Watanabe A; Ohba H; Iwayama Y; Maekawa M; Yoshikawa T
    Neurosci Res; 2010 May; 67(1):86-94. PubMed ID: 20153384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two genes, Impa1 and Impa2 encoding mouse myo-inositol monophosphatases.
    Shamir A; Sjøholt G; Ebstein RP; Agam G; Steen VM
    Gene; 2001 Jun; 271(2):285-91. PubMed ID: 11418250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).
    Yoshikawa T; Padigaru M; Karkera JD; Sharma M; Berrettini WH; Esterling LE; Detera-Wadleigh SD
    Mol Psychiatry; 2000 Mar; 5(2):165-71. PubMed ID: 10822344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes.
    Ohnishi T; Tanizawa Y; Watanabe A; Nakamura T; Ohba H; Hirata H; Kaneda C; Iwayama Y; Arimoto T; Watanabe K; Mori I; Yoshikawa T
    J Neurochem; 2013 Mar; 124(5):685-94. PubMed ID: 23205734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatment.
    Dimitrova A; Milanova V; Krastev S; Nikolov I; Toncheva D; Owen MJ; Kirov G
    Pharmacogenomics J; 2005; 5(1):35-41. PubMed ID: 15505643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.
    Yoshikawa T; Kikuchi M; Saito K; Watanabe A; Yamada K; Shibuya H; Nankai M; Kurumaji A; Hattori E; Ishiguro H; Shimizu H; Okubo Y; Toru M; Detera-Wadleigh SD
    Mol Psychiatry; 2001 Mar; 6(2):202-10. PubMed ID: 11317223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of inositol monophosphatase, the putative target of lithium therapy.
    Bone R; Springer JP; Atack JR
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10031-5. PubMed ID: 1332026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
    Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
    Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in the IMPA2 gene do not confer increased risk of febrile seizures in Caucasian patients.
    Blair MA; Ma S; Abou-Khalil B; Hedera P
    Eur J Neurol; 2007 Apr; 14(4):424-7. PubMed ID: 17388992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    Fujita S; Ohnishi T; Okuda S; Kobayashi R; Fukuno S; Furuta D; Kikuchi T; Yoshikawa T; Fujita N
    J Mol Model; 2011 Oct; 17(10):2559-67. PubMed ID: 21213002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder.
    Yoon IS; Li PP; Siu KP; Kennedy JL; Cooke RG; Parikh SV; Warsh JJ
    Mol Psychiatry; 2001 Nov; 6(6):678-83. PubMed ID: 11673796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder.
    Tomioka Y; Jiménez E; Salagre E; Arias B; Mitjans M; Ruiz V; Sáiz P; García-Portilla MP; de la Fuente L; Gomes-da-Costa SP; Bobes J; Vieta E; Benabarre A; Grande I
    J Affect Disord; 2018 May; 232():229-236. PubMed ID: 29499505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promoter polymorphism rs2075824 within IMPA2 gene affecting the transcription activity: possible relationship with schizophrenia.
    Li J; Huang S; Dai HR; Wang J; Lin LH; Xiao H; Peng X; Li F; Wang YP; Yuan JM; Li L
    J Cell Mol Med; 2017 Apr; 21(4):658-664. PubMed ID: 27748550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.